Classifies 7 Hydroxymitragynine as Schedule I drug.
This bill classifies 7 Hydroxymitragynine as a Schedule I controlled substance. This means it is considered to have no accepted medical use and a high potential for abuse.
Do you support it?
Want to know if it passes?
We'll email you when A 5359 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on A 5359.
You're tracking A 5359
We'll email you the moment it moves.
A 5359 — Classifies 7 Hydroxymitragynine as Schedule I drug.
Last action — INT 1RA REF AJU
No card. One bill, free forever — alerts when it moves.
-
1Introduced
-
2In Committee
-
3Passed General Assembly
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill has been introduced in the General Assembly. Introduced September 10, 2026. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Prognosis
Where this bill stands today.
Odds of enactment
LowHow often bills like it became law.
Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
In plain language
Classifies 7 Hydroxymitragynine as a Schedule I drug.
This bill classifies 7 Hydroxymitragynine as a Schedule I controlled substance. This means it is considered to have no accepted medical use and a high potential for abuse.
Summary
7 Hydroxymitragynine-classifies as Schedule I drug
Bill Text
- Introduced View text Current html September 11, 2026
AI-generated reading aid from the bill's amendatory text — verify against the official bill.
This bill amends 1 section(s) of the New Jersey statutes: N.J.S.A. 24:21-5.
-
N.J.S.A. 24:21-5
(24) 7 Hydroxymitragynine
amended
Action History
-
INT 1RA REF AJU
Sponsors
- Michael Inganamort · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 119 not signed on
Sponsors (1)
- Inganamort, Michael Republican
Co-sponsors (0)
None.
Not signed on (119)
119 members have not signed on to this bill.
Show all 119 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does A 5359 do?
- 7 Hydroxymitragynine-classifies as Schedule I drug
- Who sponsors A 5359?
- A 5359 is sponsored by Inganamort, Michael (Republican).
- What is the current status of A 5359?
- This bill has been introduced in the General Assembly. Introduced September 10, 2026. It must pass committee before a floor vote.
- Where can I track A 5359?
- Track A 5359 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on A 5359
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of A 5359
Last checked for changes about 1 month ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →